{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:07:05Z","timestamp":1794650825180,"version":"4.9.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"DOI":"10.1186\/s12920-025-02278-2","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T16:52:32Z","timestamp":1767631952000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association between PNPLA3 rs738409 and susceptibility to etiology-specific liver cirrhosis: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"19","author":[{"given":"Sirong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"1","key":"2278_CR1","doi-asserted-by":"publisher","first-page":"2328521","DOI":"10.1080\/07853890.2024.2328521","volume":"56","author":"Y Wang","year":"2024","unstructured":"Wang Y, Wang M, Liu C, Hao M, Wang W, Li Y, et al. Global burden of liver cirrhosis 1990\u20132019 and 20 years forecast: results from the global burden of disease study 2019. Ann Med. 2024;56(1):2328521.","journal-title":"Ann Med"},{"issue":"5","key":"2278_CR2","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.medcli.2024.11.002","volume":"164","author":"A Juanola","year":"2025","unstructured":"Juanola A, Pose E, Gines P. Liver cirrhosis: ancient disease, new challenge. Med Clin (Barc). 2025;164(5):238\u201346.","journal-title":"Med Clin (Barc)"},{"issue":"7","key":"2278_CR3","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.cgh.2024.08.020","volume":"23","author":"M Zamani","year":"2025","unstructured":"Zamani M, Alizadeh-Tabari S, Ajmera V, Singh S, Murad MH, Loomba R. Global prevalence of advanced liver fibrosis and cirrhosis in the general population: A systematic review and Meta-analysis. Clin Gastroenterol Hepatol. 2025;23(7):1123\u201334.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"2278_CR4","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1002\/jcsm.13506","volume":"15","author":"H Yang","year":"2024","unstructured":"Yang H, Ou F, Chang Q, Jiang J, Liu Y, Ji C, et al. Physical frailty, genetic predisposition, and the risks of severe non-alcoholic fatty liver disease and cirrhosis: a cohort study. J Cachexia Sarcopenia Muscle. 2024;15(4):1491\u2013500.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"e3","key":"2278_CR5","doi-asserted-by":"publisher","first-page":"e2880","DOI":"10.1136\/spcare-2024-004839","volume":"14","author":"Y Hui","year":"2024","unstructured":"Hui Y, Wang H, Guo G, Yang W, Wang X, Cui B, et al. Health-related quality of life and frailty in liver cirrhosis. BMJ Support Palliat Care. 2024;14(e3):e2880\u20137.","journal-title":"BMJ Support Palliat Care"},{"issue":"8","key":"2278_CR6","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1097\/MEG.0000000000002797","volume":"36","author":"MM Elsabaawy","year":"2024","unstructured":"Elsabaawy MM, Assem M, Badran H, Mahmoud A, Elsabaawy D, Ragab A. Impacts of rifaximin and midodrine on morbidity, mortality, and quality of life in patients with decompensated liver cirrhosis. Eur J Gastroenterol Hepatol. 2024;36(8):1022\u20138.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"2278_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jhep.2024.03.031","volume":"81","author":"MK Nadim","year":"2024","unstructured":"Nadim MK, Kellum JA, Forni L, Francoz C, Asrani SK, Ostermann M, et al. Acute kidney injury in patients with cirrhosis: acute disease quality initiative (ADQI) and international club of Ascites (ICA) joint multidisciplinary consensus meeting. J Hepatol. 2024;81(1):163\u201383.","journal-title":"J Hepatol"},{"issue":"2","key":"2278_CR8","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41591-024-03405-9","volume":"31","author":"X He","year":"2025","unstructured":"He X, Hu M, Xu Y, Xia F, Tan Y, Wang Y, et al. The gut-brain axis underlying hepatic encephalopathy in liver cirrhosis. Nat Med. 2025;31(2):627\u201338.","journal-title":"Nat Med"},{"issue":"7","key":"2278_CR9","first-page":"e63889","volume":"16","author":"S Tivaskar","year":"2024","unstructured":"Tivaskar S, Dhande R, Mishra GV, Luharia A, Naik S, Varghese AP, et al. Esophageal varices presenting with massive hematemesis in a chronic alcoholic: A case report on a rare condition. Cureus. 2024;16(7):e63889.","journal-title":"Cureus"},{"issue":"11","key":"2278_CR10","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.14309\/ajg.0000000000002778","volume":"119","author":"YT Chen","year":"2024","unstructured":"Chen YT, Chen TI, Yang TH, Yin SC, Lu SN, Liu XR, et al. Long-term risks of cirrhosis and hepatocellular carcinoma across steatotic liver disease subtypes. Am J Gastroenterol. 2024;119(11):2241\u201350.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"2278_CR11","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jhep.2024.06.016","volume":"81","author":"V Taru","year":"2024","unstructured":"Taru V, Szabo G, Mehal W, Reiberger T. Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation. J Hepatol. 2024;81(5):895\u2013910.","journal-title":"J Hepatol"},{"key":"2278_CR12","doi-asserted-by":"crossref","unstructured":"Sun T, Li S, Li X, Lei Y, Wang B, Liu X, et al. Apigenin intervenes in liver fibrosis by regulating PKM2-HIF-1alpha mediated oxidative stress. Biochem Biophys Res Commun. 2024;721:150130.","DOI":"10.1016\/j.bbrc.2024.150130"},{"key":"2278_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2024.116742","volume":"267","author":"B Wang","year":"2025","unstructured":"Wang B, Xi F, Jin C, Zhu HL, Tu M, Li Z. A ferrous fluorescence lifetime response probe for monitoring changes in lipid droplets during ferroptosis and imaging in liver disease model. Biosens Bioelectron. 2025;267:116742.","journal-title":"Biosens Bioelectron"},{"key":"2278_CR14","doi-asserted-by":"crossref","unstructured":"Akkiz H, Gieseler RK, Canbay A. Liver fibrosis: from basic science towards clinical Progress, focusing on the central role of hepatic stellate cells. Int J Mol Sci. 2024;25(14):7873.","DOI":"10.3390\/ijms25147873"},{"issue":"2","key":"2278_CR15","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/HEP.0000000000000907","volume":"81","author":"R Feio-Azevedo","year":"2025","unstructured":"Feio-Azevedo R, Boesch M, Radenkovic S, van Melkebeke L, Smets L, Wallays M, et al. Distinct immunometabolic signatures in circulating immune cells define disease outcome in acute-on-chronic liver failure. Hepatology. 2025;81(2):509\u201322.","journal-title":"Hepatology"},{"issue":"6","key":"2278_CR16","doi-asserted-by":"publisher","first-page":"539","DOI":"10.14218\/JCTH.2023.00562","volume":"12","author":"X Xu","year":"2024","unstructured":"Xu X, Feng J, Wang X, Zeng X, Luo Y, He X, et al. Mitochondrial GRIM19 loss induces liver fibrosis through NLRP3\/IL33 activation via reactive oxygen Species\/NF-small ka, CyrillicB signaling. J Clin Transl Hepatol. 2024;12(6):539\u201350.","journal-title":"J Clin Transl Hepatol"},{"key":"2278_CR17","doi-asserted-by":"crossref","unstructured":"Cheng Z, Yang L, Chu H. The role of gut microbiota, exosomes, and their interaction in the pathogenesis of ALD. J Adv Res. 2025;72353\u201367.","DOI":"10.1016\/j.jare.2024.07.002"},{"key":"2278_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12081678","author":"R Maslennikov","year":"2024","unstructured":"Maslennikov R, Benuni N, Levshina A, Adzhieva F, Demina T, Kucher A, et al. Effect of Saccharomyces boulardii on liver diseases: a systematic review. Microorganisms. 2024. https:\/\/doi.org\/10.3390\/microorganisms12081678.","journal-title":"Microorganisms"},{"issue":"4","key":"2278_CR19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/MOL.0000000000000933","volume":"35","author":"C Foster","year":"2024","unstructured":"Foster C, Gagnon CA, Ashraf AP. Altered lipid metabolism and the development of metabolic-associated fatty liver disease. Curr Opin Lipidol. 2024;35(4):200\u20137.","journal-title":"Curr Opin Lipidol"},{"issue":"5","key":"2278_CR20","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.jhep.2024.10.048","volume":"82","author":"Y Wang","year":"2025","unstructured":"Wang Y, Hong S, Hudson H, Kory N, Kinch LN, Kozlitina J, et al. PNPLA3(148M) is a gain-of-function mutation that promotes hepatic steatosis by inhibiting ATGL-mediated triglyceride hydrolysis. J Hepatol. 2025;82(5):871\u201381.","journal-title":"J Hepatol"},{"issue":"5","key":"2278_CR21","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1097\/HEP.0000000000000896","volume":"80","author":"N Chalasani","year":"2024","unstructured":"Chalasani N, Vilar-Gomez E, Loomba R, Yates KP, Diehl AM, Neuschwander-Tetri BA, et al. PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic dysfunction-associated steatotic liver disease. Hepatology. 2024;80(5):1212\u201326.","journal-title":"Hepatology"},{"issue":"5","key":"2278_CR22","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1159\/000521062","volume":"40","author":"X Shao","year":"2022","unstructured":"Shao X, Uojima H, Arai T, Ogawa Y, Setsu T, Atsukawa M, et al. The risk of cirrhosis and its complications based on PNPLA3 rs738409 G allele frequency. Dig Dis. 2022;40(5):625\u201334.","journal-title":"Dig Dis"},{"issue":"8","key":"2278_CR23","doi-asserted-by":"publisher","first-page":"e18943","DOI":"10.5812\/hepatmon.18943","volume":"14","author":"J Tong","year":"2014","unstructured":"Tong J, Guo J, Hu J, Hou S, Zhang Y, Li Q. Correlation between patatin-like phospholipase domain-containing protein 3 gene polymorphisms and liver cirrhosis in a Chinese Han population with chronic hepatitis B. Hepat Mon. 2014;14(8):e18943.","journal-title":"Hepat Mon"},{"key":"2278_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3001","author":"S Ghalamkari","year":"2018","unstructured":"Ghalamkari S, Sharafi H, Alavian SM. Association of PNPLA3 rs738409 polymorphism with liver steatosis but not with cirrhosis in patients with HBV infection: systematic review with meta-analysis. J Gene Med. 2018. https:\/\/doi.org\/10.1002\/jgm.3001.","journal-title":"J Gene Med"},{"issue":"6","key":"2278_CR25","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/apt.12890","volume":"40","author":"AJ Chamorro","year":"2014","unstructured":"Chamorro AJ, Torres JL, Miron-Canelo JA, Gonzalez-Sarmiento R, Laso FJ, Marcos M. Systematic review with meta-analysis: the I148M variant of patatin-like phospholipase domain-containing 3 gene (PNPLA3) is significantly associated with alcoholic liver cirrhosis. Aliment Pharmacol Ther. 2014;40(6):571\u201381.","journal-title":"Aliment Pharmacol Ther"},{"key":"2278_CR26","doi-asserted-by":"crossref","unstructured":"Andreas Stang. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","DOI":"10.1007\/s10654-010-9491-z"},{"issue":"2","key":"2278_CR27","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1001\/jamapsychiatry.2021.3721","volume":"79","author":"D Whiting","year":"2022","unstructured":"Whiting D, Gulati G, Geddes JR, Fazel S. Association of schizophrenia spectrum disorders and violence perpetration in adults and adolescents from 15 countries: a systematic review and meta-analysis. JAMA Psychiatr. 2022;79(2):120\u201332.","journal-title":"JAMA Psychiatr"},{"key":"2278_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2024.135219","volume":"477","author":"C Jia","year":"2024","unstructured":"Jia C, Li Y, Cao Y, Zhou Z, Liu Y, Guo Y, et al. Association between perfluoroalkyl substances and breast cancer on the National Health and Nutrition Examination Survey Database and meta-analysis. J Hazard Mater. 2024;477:135219.","journal-title":"J Hazard Mater"},{"issue":"1","key":"2278_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/ng.488","volume":"42","author":"C Tian","year":"2010","unstructured":"Tian C, Stokowski RP, Kershenobich D, Ballinger DG, Hinds DA. Variant in PNPLA3 is associated with alcoholic liver disease. Nat Genet. 2010;42(1):21\u20133.","journal-title":"Nat Genet"},{"issue":"4","key":"2278_CR30","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/hep.23606","volume":"51","author":"D Seth","year":"2010","unstructured":"Seth D, Daly AK, Haber PS, Day CP. Patatin-like phospholipase domain containing 3: a case in point linking genetic susceptibility for alcoholic and nonalcoholic liver disease. Hepatology. 2010;51(4):1463\u20135.","journal-title":"Hepatology"},{"issue":"8","key":"2278_CR31","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1111\/j.1478-3231.2011.02534.x","volume":"31","author":"E Falleti","year":"2011","unstructured":"Falleti E, Fabris C, Cmet S, Cussigh A, Bitetto D, Fontanini E, et al. PNPLA3 rs738409C\/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence. Liver Int. 2011;31(8):1137\u201343.","journal-title":"Liver Int"},{"issue":"11","key":"2278_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027087","volume":"6","author":"HD Nischalke","year":"2011","unstructured":"Nischalke HD, Berger C, Luda C, Berg T, Muller T, Grunhage F, et al. The PNPLA3 rs738409 148M\/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis. PLoS One. 2011;6(11):e27087.","journal-title":"PLoS One"},{"issue":"1","key":"2278_CR33","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/hep.24017","volume":"53","author":"F Stickel","year":"2011","unstructured":"Stickel F, Buch S, Lau K, Meyer zu Schwabedissen H, Berg T, Ridinger M, et al. Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in Caucasians. Hepatology. 2011;53(1):86\u201395.","journal-title":"Hepatology"},{"issue":"4","key":"2278_CR34","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jhep.2011.01.028","volume":"55","author":"E Trepo","year":"2011","unstructured":"Trepo E, Gustot T, Degre D, Lemmers A, Verset L, Demetter P, et al. Common polymorphism in the PNPLA3\/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease. J Hepatol. 2011;55(4):906\u201312.","journal-title":"J Hepatol"},{"issue":"2","key":"2278_CR35","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jhep.2010.10.042","volume":"55","author":"M Krawczyk","year":"2011","unstructured":"Krawczyk M, Grunhage F, Zimmer V, Lammert F. Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: non-invasive elastography-based study in chronic liver disease. J Hepatol. 2011;55(2):299\u2013306.","journal-title":"J Hepatol"},{"issue":"6","key":"2278_CR36","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S1665-2681(19)31295-5","volume":"12","author":"AK Dutta","year":"2013","unstructured":"Dutta AK. Genetic factors affecting susceptibility to alcoholic liver disease in an Indian population. Ann Hepatol. 2013;12(6):901\u20137.","journal-title":"Ann Hepatol"},{"issue":"4","key":"2278_CR37","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/hep.26445","volume":"58","author":"M Vigano","year":"2013","unstructured":"Vigano M, Valenti L, Lampertico P, Facchetti F, Motta BM, D\u2019Ambrosio R, et al. Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B. Hepatology. 2013;58(4):1245\u201352.","journal-title":"Hepatology"},{"issue":"2","key":"2278_CR38","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/liv.12695","volume":"35","author":"WP Brouwer","year":"2015","unstructured":"Brouwer WP, van der Meer AJ, Boonstra A, Pas SD, de Knegt RJ, de Man RA, et al. The impact of PNPLA3 (rs738409 C\u2009>\u2009G) polymorphisms on liver histology and long-term clinical outcome in chronic hepatitis B patients. Liver Int. 2015;35(2):438\u201347.","journal-title":"Liver Int"},{"issue":"3","key":"2278_CR39","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/jgh.13536","volume":"32","author":"AW Chan","year":"2017","unstructured":"Chan AW, Wong GL, Chan HY, Tong JH, Yu YH, Choi PC, et al. Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B. J Gastroenterol Hepatol. 2017;32(3):667\u201376.","journal-title":"J Gastroenterol Hepatol"},{"key":"2278_CR40","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aba4448","author":"O Govaere","year":"2020","unstructured":"Govaere O, Cockell S, Tiniakos D, Queen R, Younes R, Vacca M, et al. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis. Sci Transl Med. 2020. https:\/\/doi.org\/10.1126\/scitranslmed.aba4448.","journal-title":"Sci Transl Med"},{"key":"2278_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2020.08.065","author":"DI Peregud","year":"2021","unstructured":"Peregud DI, Baronets VY, Lobacheva AS, Ivanov AS, Arisheva OS, Garmash IV, et al. PNPLA3 rs738409 associates with alcoholic liver cirrhosis but not with serum levels of IL6, IL10, IL8 or CCL2 in the Russian population. Ann Hepatol. 2021. https:\/\/doi.org\/10.1016\/j.aohep.2020.08.065.","journal-title":"Ann Hepatol"},{"key":"2278_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.822700","volume":"13","author":"KC Hsueh","year":"2022","unstructured":"Hsueh KC, Nfor ON, Hsu SY, Yang SF, Liaw YP. Type 2 diabetes, PNPLA3 rs738409 polymorphism, and the risk of liver cirrhosis: analysis of Taiwan Biobank. Front Genet. 2022;13:822700.","journal-title":"Front Genet"},{"key":"2278_CR43","doi-asserted-by":"crossref","unstructured":"Mohamed Fteah A, Abdel Rahim A, Ahmed AbdelHady A, Shawky H, Mamdouh Aly MAE. D. Association of PNPLA3 (rs738409) & TM6SF2 (rs58542926) and ATG16L1 (rs2241880) genetic variants with susceptibility to hepatocellular carcinoma in a group of Egyptian patients with HCV-induced liver cirrhosis. Tumour Virus Res. 2023;15:200256.","DOI":"10.1016\/j.tvr.2023.200256"},{"issue":"1","key":"2278_CR44","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.dld.2015.09.009","volume":"48","author":"E Falleti","year":"2016","unstructured":"Falleti E, Cussigh A, Cmet S, Fabris C, Toniutto P. PNPLA3 rs738409 and TM6SF2 rs58542926 variants increase the risk of hepatocellular carcinoma in alcoholic cirrhosis. Dig Liver Dis. 2016;48(1):69\u201375.","journal-title":"Dig Liver Dis"},{"issue":"5","key":"2278_CR45","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s12664-017-0784-y","volume":"36","author":"S Alam","year":"2017","unstructured":"Alam S, Islam MS, Islam S, Mustafa G, Saleh AA, Ahmad N. Association of single nucleotide polymorphism at PNPLA3 with fatty liver, steatohepatitis, and cirrhosis of liver. Indian J Gastroenterol. 2017;36(5):366\u201372.","journal-title":"Indian J Gastroenterol"},{"issue":"8","key":"2278_CR46","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3109\/00365521.2016.1161066","volume":"51","author":"U Vespasiani-Gentilucci","year":"2016","unstructured":"Vespasiani-Gentilucci U, Gallo P, Porcari A, Carotti S, Galati G, Piccioni L, et al. The PNPLA3 rs738409 C\u2009>\u2009G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients. Scand J Gastroenterol. 2016;51(8):967\u201373.","journal-title":"Scand J Gastroenterol"},{"issue":"10","key":"2278_CR47","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1080\/00365521.2017.1334088","volume":"52","author":"X Gao","year":"2017","unstructured":"Gao X, Liu W, Yang L, Zhang X, Ma N, Wang L, et al. Association between PNPLA3 gene polymorphisms and risk of hepatitis B virus-related hepatocellular carcinoma in Han population in China:a case-control study. Scand J Gastroenterol. 2017;52(10):1120\u20137.","journal-title":"Scand J Gastroenterol"},{"issue":"10","key":"2278_CR48","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/s41588-023-01497-6","volume":"55","author":"Y Chen","year":"2023","unstructured":"Chen Y, Du X, Kuppa A, Feitosa MF, Bielak LF, O\u2019Connell JR, et al. Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease. Nat Genet. 2023;55(10):1640\u201350.","journal-title":"Nat Genet"},{"issue":"1","key":"2278_CR49","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1194\/jlr.M048777","volume":"56","author":"JH Shen","year":"2015","unstructured":"Shen JH, Li YL, Li D, Wang NN, Jing L, Huang YH. The rs738409 (I148M) variant of the PNPLA3 gene and cirrhosis: a meta-analysis. J Lipid Res. 2015;56(1):167\u201375.","journal-title":"J Lipid Res"},{"issue":"3","key":"2278_CR50","doi-asserted-by":"publisher","DOI":"10.1111\/liv.16106","volume":"45","author":"EK Speliotes","year":"2025","unstructured":"Speliotes EK, Schneider CV. PNPLA3 I148M interacts with environmental triggers to cause human disease. Liver Int. 2025;45(3):e16106.","journal-title":"Liver Int"},{"issue":"4","key":"2278_CR51","doi-asserted-by":"publisher","DOI":"10.1111\/liv.16186","volume":"45","author":"D Linden","year":"2025","unstructured":"Linden D, Tesz G, Loomba R. Targeting PNPLA3 to treat MASH and MASH related fibrosis and cirrhosis. Liver Int. 2025;45(4):e16186.","journal-title":"Liver Int"},{"issue":"18","key":"2278_CR52","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2318619121","volume":"121","author":"DJ Sherman","year":"2024","unstructured":"Sherman DJ, Liu L, Mamrosh JL, Xie J, Ferbas J, Lomenick B, et al. The fatty liver disease-causing protein PNPLA3-I148M alters lipid droplet-Golgi dynamics. Proc Natl Acad Sci U S A. 2024;121(18):e2318619121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2278_CR53","doi-asserted-by":"publisher","first-page":"672","DOI":"10.4049\/jimmunol.2001453","volume":"208","author":"W Li","year":"2022","unstructured":"Li W, Duan X, Zhu C, Liu X, Jeyarajan AJ, Xu M, et al. Hepatitis B and hepatitis C virus infection promote liver fibrogenesis through a TGF-beta1-Induced OCT4\/Nanog pathway. J Immunol. 2022;208(3):672\u201384.","journal-title":"J Immunol"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02278-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-025-02278-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02278-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T17:03:11Z","timestamp":1767632591000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12920-025-02278-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2278"],"URL":"https:\/\/doi.org\/10.1186\/s12920-025-02278-2","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}